AMENDMENT #2 TO CONVERTIBLE PROMISSORY NOTEConvertible Promissory Note • July 28th, 2023 • NRX Pharmaceuticals, Inc. • Pharmaceutical preparations
This Amendment #2 to Convertible Promissory Note (this “Amendment”) is entered into as of July 7, 2023, by and between Streeterville Capital, LLC, a Utah limited liability company (“Lender”), and NRX Pharmaceuticals, Inc., a Delaware corporation (“Borrower”). Capitalized terms used in this Amendment without definition shall have the meanings given to them in the Note (as defined below) and Amendment #1 (as defined below).
